CORVAS INTERNATIONAL INC 4
4 · CORVAS INTERNATIONAL INC · Filed Jul 31, 2003
Insider Transaction Report
Form 4
BVF PARTNERS L P/IL
10% Owner
Transactions
- Sale
Common Stock
2003-07-29$2.87/sh−1,000$2,870→ 1,166,555 total(indirect: See Footnotes)
Footnotes (4)
- [F1]The shares reported in this response are indirectly beneficially owned by BVF Partners L.P., a Delaware limited partnership ("Partners"), the designated filer of this joint filing on Form 4, and by its general partner ("GP"), BVF Inc., a Delaware corporation ("BVF Inc."), which is also an investment advisor to Partners. Partners is the GP of Biotechnology Value Fund, L.P., a Delaware limited partnership ("BVF, L.P.") and Biotechnology Value Fund II, L.P., a Delaware limited partnership ("BVF2, L.P."), both investment limited partnerships. Partners also is the manager of BVF Investments L.L.C., a Delaware limited liability company ("Investments"). Following the transactions reported in Table I, Item 5, Partners and BVF Inc. indirectly beneficially own in the aggregate 3,010,893 shares of common stock of Corvas International, Inc.
- [F2]Pursuant to the operating agreement of Investments, Partners is authorized, among other things, to invest the funds of Ziff Asset Management, L.P., the majority member of Investments, in the shares of common stock reported in Table I as being beneficially owned by Investments. Mark N. Lampert is the sole shareholder and sole director of BVF Inc., and is an officer of BVF Inc. This joint filing on Form 4 shall not be deemed an admission that Mark N. Lampert is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any equity securities covered by this joint filing.
- [F3]Shares are directly beneficially owned by BVF, L.P.
- [F4]Shares are directly beneficially owned by Investments.